当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析 - 现金流量表

浙江医药

(600216)

  

流通市值:134.72亿  总市值:134.73亿
流通股本:9.62亿   总股本:9.62亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金7,005,114,859.744,504,384,317.322,152,467,494.588,721,539,348.05
  收到的税费返还398,671,381.35345,238,593.73221,100,668.61285,978,456.89
  收到其他与经营活动有关的现金113,340,958.0183,503,024.9236,945,902.13123,406,697.08
  经营活动现金流入小计7,517,127,199.14,933,125,935.972,410,514,065.329,130,924,502.02
  购买商品、接受劳务支付的现金3,681,699,974.682,406,085,754.181,103,824,099.44,723,833,724.64
  支付给职工以及为职工支付的现金774,221,238.49566,846,592.13355,817,531.64985,718,949.68
  支付的各项税费698,622,952.68545,984,460.13323,331,597.57638,536,697.14
  支付其他与经营活动有关的现金873,917,259.34616,027,924.49322,576,185.711,559,536,488.61
  经营活动现金流出小计6,028,461,425.194,134,944,730.932,105,549,414.327,907,625,860.07
  经营活动产生的现金流量净额1,488,665,773.91798,181,205.04304,964,6511,223,298,641.95
二、投资活动产生的现金流量:
  收回投资收到的现金824,723,419.38419,142,568.18196,550,719.59426,771,794.12
  取得投资收益收到的现金500,558.14417,234.547501,074,717.23
  处置固定资产、无形资产和其他长期资产收回的现金净额1,161,360.29327,832-200,492,312.39
  收到的其他与投资活动有关的现金695,205,845.38489,559,410.93276,368,513.26583,369,145.09
  投资活动现金流入小计1,521,591,183.19909,447,045.65472,919,982.851,211,707,968.83
  购建固定资产、无形资产和其他长期资产支付的现金288,220,093.07208,193,588.87140,229,317.07689,143,769.13
  投资支付的现金838,899,992.56425,781,417.86195,436,665.94453,164,069.28
  支付其他与投资活动有关的现金637,500,000402,500,000255,677,242.74542,900,000
  投资活动现金流出小计1,764,620,085.631,036,475,006.73591,343,225.751,685,207,838.41
  投资活动产生的现金流量净额-243,028,902.44-127,027,961.08-118,423,242.9-473,499,869.58
三、筹资活动产生的现金流量:
  取得借款收到的现金546,577,625.82495,000,000185,000,000520,000,000
  筹资活动现金流入小计546,577,625.82495,000,000185,000,000520,000,000
  偿还债务支付的现金341,500,000338,000,000137,000,000573,000,000
  分配股利、利润或偿付利息支付的现金370,696,311.3411,848,151.425,771,240.27172,291,361.34
  其中:子公司支付给少数股东的股利、利润---1,984,887.82
  支付其他与筹资活动有关的现金202,029,611.85136,919,330-30,029,514.92
  筹资活动现金流出小计914,225,923.19486,767,481.42142,771,240.27775,320,876.26
  筹资活动产生的现金流量净额-367,648,297.378,232,518.5842,228,759.73-255,320,876.26
四、汇率变动对现金及现金等价物的影响55,426,355.6863,636,449.1822,827,650.8311,267,874.76
五、现金及现金等价物净增加额933,414,929.78743,022,211.72251,597,818.66505,745,770.87
  加:期初现金及现金等价物余额1,965,585,411.061,965,585,411.061,965,585,411.061,459,839,640.19
  期末现金及现金等价物余额2,899,000,340.842,708,607,622.782,217,183,229.721,965,585,411.06
补充资料:
  净利润-624,571,156.24-1,020,251,510.18
  资产减值准备-79,707,143.85-263,898,853.78
  固定资产和投资性房地产折旧-340,383,586.5-639,659,876.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-340,383,586.5-639,659,876.73
  无形资产摊销-41,490,056.32-82,275,878.61
  长期待摊费用摊销-2,246,163.14-3,539,035.51
  处置固定资产、无形资产和其他长期资产的损失--178,709.95--3,090,739.73
  固定资产报废损失-1,132,404-8,303,514.39
  公允价值变动损失--1,276,670.78-21,534,114.35
  财务费用--90,577,420.59-8,584,495.11
  投资损失-3,372,533.17-8,069,379.83
  递延所得税--19,334,508.99--42,814,569.64
  其中:递延所得税资产减少--19,334,508.99--42,814,569.64
  存货的减少--179,104,430.32--347,256,415.96
  经营性应收项目的减少-250,080,707.79--759,439,761.11
  经营性应付项目的增加--249,561,761.6-305,365,146.09
  其他---13,692,854.83
  现金的期末余额-2,708,607,622.78-1,965,585,411.06
  减:现金的期初余额-1,965,585,411.06-1,459,839,640.19
  现金及现金等价物的净增加额-743,022,211.72-505,745,770.87
公告日期2025-10-282025-08-262025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑